Irreversible Blockade of Beta-adrenergic Receptors with a Bromoacetyl Derivative of Pindolol

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1985 Jan 1

PMID 2858822

Authors

V Homburger

H Gozlan

R Bouhelal

M Lucas

J Bockaert

Affiliations

Soon will be listed here.

Abstract

A potent irreversible beta-adrenergic derivative of pindolol possessing a chemically reactive group (Br-AAM-pindolol) was synthesized. This compound devoid of agonist properties, competed for all (3H)-dihydroalprenolol (3H-DHA) binding sites in C6 glioma cell and rat cerebellum membranes. Pretreatment of C6 glioma cell membranes with Br-AAM-pindolol and subsequent washing resulted in a time- and dose-dependent blockade of beta-adrenergic receptors. A 50% blockade was achieved in the presence of 1.6 nM Br-AAM-pindolol. This blockade occurs specifically at the beta-adrenergic receptor level, as: 1) it induced a decrease of maximal isoproterenol stimulated adenylate cyclase activity with no modification of basal and sodium fluoride stimulated activity and 2) decreases of (3H)-DHA binding and stimulation of adenylate cyclase activity by the agonist were suppressed in the presence of isoproterenol, a beta-adrenergic agonist. Furthermore, Br-AAM-pindolol treatment did not affect (3H)-diazepam binding in C6 glioma cell membranes. Pretreatment of C6 glioma cells with Br-AAM-pindolol also reduced the response of adenylate cyclase to isoproterenol and the number of beta-adrenergic receptors. The blockade of beta-adrenergic receptors of C6 glioma cells by Br-AAM-pindolol was non-competitive, whereas the blockade obtained with AM-pindolol, a derivative of pindolol devoid of alkylating properties, was competitive. The irreversible blockade of beta-adrenergic receptors by Br-AAM-pindolol in rat erythrocyte membranes was substantiated by the demonstration that no recovery of beta-adrenergic receptors occurred during long term incubation of the membranes (48 h) following Br-AAM-pindolol treatment and subsequent washing.(ABSTRACT TRUNCATED AT 250 WORDS)

References

Rashidbaigi A, Ruoho A . Iodoazidobenzylpindolol, a photoaffinity probe for the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1981; 78(3):1609-13. PMC: 319181. DOI: 10.1073/pnas.78.3.1609. View

Venter J . High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors. Mol Pharmacol. 1979; 16(2):429-40. View

Burgermeister W, Hekman M, Helmreich E . Photoaffinity labeling of the beta-adrenergic receptor with azide derivatives of iodoccyanopindolol. J Biol Chem. 1982; 257(9):5306-11. View

Broadley K, Nicholson C . Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist. Br J Pharmacol. 1981; 72(4):635-43. PMC: 2071640. DOI: 10.1111/j.1476-5381.1981.tb09143.x. View

Shorr R, Heald S, JEFFS P, Lavin T, Strohsacker M, Lefkowitz R . The beta-adrenergic receptor: rapid purification and covalent labeling by photoaffinity crosslinking. Proc Natl Acad Sci U S A. 1982; 79(9):2778-82. PMC: 346289. DOI: 10.1073/pnas.79.9.2778. View

Ruoho A, Kiefer H, Roeder P, Singer S . The mechanism of photoaffinity labeling. Proc Natl Acad Sci U S A. 1973; 70(9):2567-71. PMC: 427057. DOI: 10.1073/pnas.70.9.2567. View

Homcy C, Rockson S, Countaway J, Egan D . Purification and characterization of the mammalian beta 2-adrenergic receptor. Biochemistry. 1983; 22(3):660-8. DOI: 10.1021/bi00272a021. View

Kunos G, Kan W, Greguski R, Venter J . Selective affinity labeling and molecular characterization of hepatic alpha 1-adrenergic receptors with [3H]phenoxybenzamine. J Biol Chem. 1983; 258(1):326-32. View

Atlas D, Levitzki A . Tentative identification of beta-adrenoreceptor subunts. Nature. 1978; 272(5651):370-1. DOI: 10.1038/272370a0. View

10.

Kaumann A, BLINKS J . beta-Adrenoceptor blocking agents as partial agonists in isolated heart muscle: dissociation of stimulation and blockade. Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(3):237-48. DOI: 10.1007/BF00569403. View

11.

Minneman K, Hegstrand L, Molinoff P . Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979; 16(1):34-46. View

12.

Lucas M, Bockaert J . Use of (-)-[3H]dihydroalprenolol to study beta adrenergic receptor-adenylate cyclase coupling in C6 glioma cells: role of 5'-guanylylimidodiphosphate. Mol Pharmacol. 1977; 13(2):314-29. View

13.

Terasaki W, Linden J, Brooker G . Quantitative relationship between beta-adrenergic receptor number and physiologic responses as studied with a long-lasting beta-adrenergic antagonist. Proc Natl Acad Sci U S A. 1979; 76(12):6401-5. PMC: 411872. DOI: 10.1073/pnas.76.12.6401. View

14.

Homburger V, Lucas M, CANTAU B, Barabe J, Penit J, Bockaert J . Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps. Modification of the coupling and loss of beta-adrenergic receptors. J Biol Chem. 1980; 255(21):10436-44. View

15.

Merlie J, Heinemann S, Lindstrom J . Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies. J Biol Chem. 1979; 254(14):6320-7. View

16.

Lavin T, Heald S, JEFFS P, Shorr R, Lefkowitz R, Caron M . Photoaffinity labeling of the beta-adrenergic receptor. J Biol Chem. 1981; 256(22):11944-50. View

17.

Darfler F, Marinetti G . Synthesis of a photoaffinity probe for the beta-adrenergic receptor. Biochem Biophys Res Commun. 1977; 79(1):1-7. DOI: 10.1016/0006-291x(77)90052-3. View

18.

UPrichard D, Bylund D, Snyder S . (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem. 1978; 253(14):5090-102. View

19.

Baker S, Pitha J . Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo. J Pharmacol Exp Ther. 1982; 220(2):247-51. View

20.

Guellaen G, Aggerbeck M, Hanoune J . Characterization and solubilization of the alpha-adrenoreceptor of rat liver plasma membranes labeled with [3H]phenoxybenzamine. J Biol Chem. 1979; 254(21):10761-8. View